Skip to main content
. 2018 Jan 6;175(4):631–643. doi: 10.1111/bph.14110

Figure 1.

Figure 1

ABPPk increases cell viability in MPP+‐treated cells. (A, B) The SH‐SY5Y cells were pretreated with ABPPk at different dosages and subjected to 500 μM MPP+. The cell viability (A) and LDH activity in the culture medium (B) were analysed. (C, D) Results from rat primary dopaminergic neurons (DNs) pretreated with ABPPk at different dosages and subjected to 50 μM MPP+. The cell viability (C) and LDH activity (D) were assayed. Error bars are ± SEM. n = 5. *P < 0.05 versus the vehicle treated cells. #P < 0.05 versus the cells treated with MPP+ alone.